Navigation Links
3SBio Inc. Announces Unaudited Third Quarter 2009 Results
Date:11/12/2009

) on a GAAP basis, and increased by 19.0% over the first nine months of 2008 to RMB75.8 million (US$11.1 million) on a non-GAAP basis. -- Net income per ADS on a fully-diluted basis for the first nine months of 2009 was RMB3.24 (US$0.47) compared with RMB1.89 (US$0.28) for the first nine months of 2008 on a GAAP basis, and RMB3.52 (US$0.52) compared with RMB2.93 (US$0.43) for the first nine months of 2008 on a non-GAAP basis. Third Quarter 2009 Business Highlights -- EPIAO, the Company's flagship injectable recombinant human erythropoietin ("EPO") product, demonstrated strong growth with net revenue from EPIAO in the third quarter of 2009 rising 32.6% to RMB56.6 million (US$8.3 million) compared to RMB42.7 million (US$6.3 million) in the third quarter of 2008. -- Net revenues for TPIAO, the Company's novel recombinant human thrombopoietin ("TPO") product, increased by 41.3% to RMB27.9 million (US$4.1 million) in the third quarter of 2009, compared to RMB19.7 million (US$2.9 million) in the third quarter of 2008. -- Construction of the new EPIAO and TPIAO manufacturing plant in Shenyang remains on schedule for completion this year in preparation for validation and certification next year. -- Dr. Jing Lou, chief executive officer of 3SBio, commented: "Overall, the business is performing as expected with a strong set of results this quarter and we reiterate our full-year guidance of US$43-45 million. Construction of our new plant remains on schedule and we look forward to moving to validation and certification next year. We continued to develop our product pipeline and will update the market when we have reached significant milestones in the approval process." Three months ended September 30, 2009 Unaudited Financial Results

Net revenues. Net revenues increased by 35.8% to R
'/>"/>

SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
2. 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
3. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
4. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
5. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
6. 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
7. 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
8. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
9. 3SBio Inc. Announces Third Quarter 2008 Results
10. 3SBio Inc. Files for SFDA Approval of NuLeusin
11. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... Clarassance, a privately held clinical-stage biotechnology company based ... Therapeutics , Inc. The new name is derived from ... in the lungs similar to branches on a tree), ... therapeutics for the treatment of respiratory diseases. , ... to mark the company's escalation into the clinical phase ...
(Date:12/13/2014)... 2014 According to population studies: “North ... now and 2030." If a population explosion like that ... populous state in the country. , To that end, ... Future of North Carolina Forum on December 16th to ... the necessary infrastructure in place? Enough clean water? And ...
(Date:12/13/2014)... ROCHESTER, N.Y. , Dec. 12, 2014 ... engaged in the discovery and development of ... neurodegenerative diseases, today announced publication of a ... microglia, and inhibits remyelination in neurodegenerative disease" ... journal Neurobiology of Disease*.  The publication highlights ...
(Date:12/12/2014)... 2014 Pittcon is pleased to ... includes over 2,000 technical presentations offered in symposia, ... year’s program covers a wide range of applications ... drug discovery, environmental, food science, fuels/energy, genomics, lab ... The Technical Program begins on Sunday, March ...
Breaking Biology Technology:Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2Pittcon Announces a Diverse 2015 Technical Program - Renowned Speakers, Special Symposia and Co-programming 2Pittcon Announces a Diverse 2015 Technical Program - Renowned Speakers, Special Symposia and Co-programming 3
... June 5 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ... enrolment in a Phase II clinical trial using ... in patients with advanced head and neck cancers. ... Institute of Cancer Research,and The Royal Marsden NHS ...
... Contract Provides for the Sale of Ready to Drink,Suite of Nutritional ... ... or 142%, BASKING RIDGE, N.J., June 5 Millennium Biotechnologies,Inc., ... announced today that it has entered into an,amendment of it,s November ...
... 5 Crystal Research Associates, LLC,announced today that ... Arana Therapeutics Ltd. (AAH: ASX). The full 56-page ... Arana Therapeutics Ltd. ("Arana" or "the Company") ... treat,inflammatory diseases and cancer. Arana,s business is divided ...
Cached Biology Technology:Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc. 2Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc. 3Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 3
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... -- C-Labs LLC, a leading provider of remote and ... announced the appointment of John Traynor to ... advisor to the firm, Mr. Traynor will now oversee ... out of the C-Labs office in Redmond, ... , Chief Executive Officer. Photo - ...
(Date:11/18/2014)...   News Highlights: ... The Partners Data Lake, an agile data and ... will allow researcher and clinicians to explore and ... lives of patients , The Partners Data ... the Partners system, breaking down physical barriers for ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... (March 9, 2009)A new study shows that for those ... you,re young or old: arteriovenous (AV) fistulas remain the ... to provide life-sustaining dialysis. Interventional radiologists found no difference ... "patency" or the openness of AV fistulas or accesses ...
... who ate fish at least once a week displayed higher cognitive ... it less frequently, according to a study of nearly 4,000 teenagers ... Eating fish once a week was enough to increase ... per cent, while eating fish more than once a week increased ...
... 9, 2009 Good eating habits can result when ... the Journal of Nutrition Education and Behavior , ... Minnesota report on one of the first studies to ... diet quality during the transition from early to middle ...
Cached Biology News:For old or young dialysis patients, AV fistulas remain pure gold 2For old or young dialysis patients, AV fistulas remain pure gold 3Teenage boys who eat fish at least once a week achieve higher intelligence scores 2Teenage boys who eat fish at least once a week achieve higher intelligence scores 3Regular family meals result in better eating habits for adolescents 2
... Array CGH Genomic Labeling Systems are a ... of genomic DNA samples for array-based Comparative ... and direct labeling formats, the BioPrime Plus ... flexible solution to your genomic labeling needs. ...
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
... - Monolayer is a system designed for ... in a serum-free environment. The kit contains a ... been optimized for neural stem cell expansion (Johe, ... Development 10 :3129). Human fibroblast growth factor ...
... DNA Polymerase I from E. ... polymerase. The enzyme also contains ... The 5'?3' exonuclease activity enables ... and gaps in the DNA ...
Biology Products: